다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
NASDAQ
Day One Biopharmaceuticals Inc (DAWN)
Day One Biopharmaceuticals Inc (DAWN) 뉴스

DAWN

Day One Biopharmaceuticals (DAWN)

Day One Biopharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:DAWN

1 2 3 4 5 6 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/30	21:35	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2024/05/29	07:17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2024/05/25	05:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2024/05/18	07:27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2024/05/18	07:18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2024/05/17	07:34	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2024/05/17	07:21	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2024/05/15	07:13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2024/05/07	05:35	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2024/05/07	05:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2024/03/08	06:19	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2024/02/29	09:55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2024/02/28	06:27	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2024/02/21	08:26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2024/02/21	08:14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2024/02/17	07:51	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2024/01/17	22:25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2024/01/10	09:22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2024/01/10	09:17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2024/01/08	22:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2024/01/05	06:06	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2023/11/18	08:26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2023/11/18	08:20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2023/11/17	21:07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2023/11/17	08:24	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2023/11/16	06:07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2023/11/07	06:48	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2023/11/07	06:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2023/10/30	23:54	Dow Jones News	Day One Biopharmaceuticals Shares Rally on FDA Priority Review	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2023/10/30	21:58	Dow Jones News	Day One Gets FDA Priority Review of Tovorafenib in Pediatric Brain Tumor	NASDAQ:DAWN	Day One Biopharmaceuticals Inc

검색 관련기사 보기:NASDAQ:DAWN

1 2 3 4 5 6 다음 >>

Maudore Minerals (CE)

Vontobel Financial Produ...

NLBNPIT214N5 20991231 69...

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관